1. Home
  2. REED vs BEAT Comparison

REED vs BEAT Comparison

Compare REED & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

REED

Reed's Inc.

N/A

Current Price

$3.58

Market Cap

42.8M

Sector

N/A

ML Signal

N/A

Logo Heartbeam Inc.

BEAT

Heartbeam Inc.

HOLD

Current Price

$0.86

Market Cap

44.8M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
REED
BEAT
Founded
1987
2015
Country
United States
United States
Employees
44
16
Industry
Retail: Computer Software & Peripheral Equipment
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
42.8M
44.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
REED
BEAT
Price
$3.58
$0.86
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.63
AVG Volume (30 Days)
9.9K
1.4M
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$18.74
N/A
Revenue Next Year
$18.00
$315.97
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.75
$0.54
52 Week High
$5.97
$4.00

Technical Indicators

Market Signals
Indicator
REED
BEAT
Relative Strength Index (RSI) 46.96 35.88
Support Level $3.50 $0.80
Resistance Level $4.35 $1.29
Average True Range (ATR) 0.42 0.07
MACD -0.07 0.00
Stochastic Oscillator 41.67 29.97

Price Performance

Historical Comparison
REED
BEAT

About REED Reed's Inc.

Reed's Inc is a branded beverage company offering a portfolio of natural, premium, and functional beverages under the Reed's and Virgil's brands. The company's portfolio of handcrafted, all-natural beverages is sold in outlets nationwide, including the natural and specialty food channel, grocery stores, mass merchants, drug stores, convenience stores, club stores, and on-premise locations, including bars and restaurants. The company operates in a single reportable segment, which consists of manufacturing carbonated beverages under Reed's and Virgil's brand names.

About BEAT Heartbeam Inc.

HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.

Share on Social Networks: